Frazier Life Sciences VIII, L.P.'s Net Worth
$67 Million
Who is Frazier Life Sciences VIII, L.P.?
Frazier Life Sciences VIII, L.P. has an estimated net worth of $67 Million. This is based on reported shares across multiple companies, which include ALPINE IMMUNE SCIENCES, INC., Arcutis Biotherapeutics, Inc., Sierra Oncology, Inc., Entasis Therapeutics Holdings Inc., and Aptinyx Inc..
SEC CIK
Frazier Life Sciences VIII, L.P.'s CIK is 0001655827
Past Insider Trading and Trends
2018 was Frazier Life Sciences VIII, L.P.'s most active year for acquiring shares with 8 total transactions. Frazier Life Sciences VIII, L.P.'s most active month to acquire stocks was the month of January. 2020 was Frazier Life Sciences VIII, L.P.'s most active year for disposing of shares, totalling 4 transactions. Frazier Life Sciences VIII, L.P.'s most active month to dispose stocks was the month of August. 2020 saw Frazier Life Sciences VIII, L.P. paying a total of $8,500,000.00 for 10,033,758 shares, this is the most they've acquired in one year. In 2020 Frazier Life Sciences VIII, L.P. cashed out on 9,583,758 shares for a total of $250,010.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALPINE IMMUNE SCIENCES, INC. (ALPN) No price found
InvestorFrazier Life Sciences VIII, L.P. owns 1,484,115 units of Common Stock. From 2017 to 2019 Frazier Life Sciences VIII, L.P. acquired a total of 485,104 shares in ALPINE IMMUNE SCIENCES, INC. at a cost of $2,799,986.53, Frazier also disposed a total of 1,200,000 shares of ALPINE IMMUNE SCIENCES, INC..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.22% | 112.67K |
$7.10 | $799,989.10 | 1.48M |
Feb 11
| |||
Form 4
| -46.67% | -1.20M |
—
|
—
| 1.37M |
Sep 17
| |||
Form 4
| +16.94% | 372.44K |
$5.37 | $1,999,997.43 | 2.57M |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $10.38
InvestorFrazier Life Sciences VIII, L.P. owns 8,764,232 units of Common Stock which is worth $90,972,728.16. From 2020 to 2023 Frazier Life Sciences VIII, L.P. acquired a total of 10,363,758 shares in Arcutis Biotherapeutics, Inc. at a cost of $13,700,000.00, Frazier also disposed a total of 2,108,558 shares of Arcutis Biotherapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.92% | 80K |
$2.50 | $200,000.00 | 8.76M |
Oct 24
| |||
Form 4
| +2.96% | 250K |
$20.00 | $5,000,000.00 | 8.68M |
Aug 5
| |||
Form 4
| -20.00% | -2.11M |
—
|
—
| 8.43M |
May 10
| |||
Form 4
| +1,971.14% | 10.03M |
$17.00 |
—
| 10.54M |
Feb 4
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entasis Therapeutics Holdings Inc. No price found
InvestorFrazier Life Sciences VIII, L.P. owns 1,299,953 units of Common Stock. In the year 2018 Frazier Life Sciences VIII, L.P. filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.70% | -50.00K |
$5.00 | -$250,010.00 | 1.3M |
Jan 9
| |||
Form 4
| +196.88% | 1.29M |
$15.00 |
—
| 1.94M |
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aptinyx Inc. (APTX) Snapshot price: $0.09
InvestorFrazier Life Sciences VIII, L.P. owns 3,190,079 units of Common Stock which is worth $287,107.11. In the year 2018 Frazier Life Sciences VIII, L.P. filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.19M |
$16.00 |
—
| 3.19M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||